Hepatitis B virus activity in patients with anti-hepatitis C virus antibody positivity and hepatitis B antigen positivity
✍ Scribed by Alexander C Haushofer; René Hauer; Harald Brunner; Ursula Köller; Doris Trubert-Exinger; Walter-Michael Halbmayer; Josef Haas; Harald H Kessler
- Book ID
- 117769648
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 93 KB
- Volume
- 25
- Category
- Article
- ISSN
- 1386-6532
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ؍ 60
Delta antigen is currently thought to reflect superinfection of the liver with a defective RNA virus (delta agent), requiring helper function from hepatitis B virus for its replication. To assess the influence of delta agent on hepatitis B virus replication in patients persistently infected with bot